Resistant protein for use in herbicide, encoding gene and application thereof
US-2019249187-A1 · Aug 15, 2019 · US
US12545932B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12545932-B2 |
| Application number | US-202117224596-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 7, 2021 |
| Priority date | Nov 25, 2020 |
| Publication date | Feb 10, 2026 |
| Grant date | Feb 10, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A recombinant microorganism including a genetic modification that increases activity of nitric oxide reductase in the recombinant microorganism, a composition for reducing a concentration of nitric oxide in a sample, the composition including the recombinant microorganism, and a method of reducing a concentration of nitric oxide in a sample, are disclosed.
Opening claim text (preview).
What is claimed is: 1 . A recombinant bacterium comprising a genetic modification that increases expression of a gene encoding a nitric oxide reductase in the recombinant bacterium, wherein the recombinant bacterium belongs to the genus Escherichia or the genus Paracoccus , wherein the gene originates from Paracoccus versutus and wherein the nitric oxide reductase comprises a polypeptide having 95% or greater sequence identity to a polypeptide encoded by SEQ ID NO:21. 2 . A composition for reducing a concentration of nitric oxide in a sample, the composition comprising the recombinant bacterium according to claim 1 . 3 . A method of reducing a concentration of nitric oxide in a sample containing nitric oxide, the method comprising contacting the sample with the recombinant bacterium according to claim 1 . 4 . The method of claim 3 , wherein the genetic modification increases the copy number of the gene encoding the nitric oxide reductase. 5 . The method of claim 3 , wherein the nitric oxide (NO) is in a form of Fe(II)(L)—NO, which is a complex formed by chelating a chelating agent L with Fe 2+ and NO. 6 . The method of claim 3 , wherein the contacting is performed in a sealed container. 7 . The method of claim 3 , wherein the contacting comprises culturing or incubating the recombinant bacterium in the presence of the nitric oxide-containing sample. 8 . The method of claim 3 , wherein the contacting comprises culturing the recombinant bacterium in a sealed container and under conditions in which the recombinant bacterium grows. 9 . The recombinant bacterium of claim 1 , wherein the genetic modification increases the copy number of the gene encoding the nitric oxide reductase. 10 . The method of claim 3 , wherein the sample is in a liquid state or gas state.
acting on other nitrogen compounds as donors (1.7) · CPC title
Bacteria; Culture media therefor · CPC title
Nitric-oxide reductase (cytochrome c)(1.7.2.5) · CPC title
Biological processes · CPC title
Enzymatic · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.